Clinical Study

Different Impacts of Metabolic Syndrome Components on Insulin Resistance in Type 2 Diabetes

Table 1

Comparison of characteristics among quartiles of HOMA insulin resistance index.

VariableQuartiles of HOMA insulin resistance index for trend
1
Mean (SD)
2
Mean (SD)
3
Mean (SD)
4
Mean (SD)

Basic data
 HOMA IR*1.7 (0.7)3.2 (0.4)4.9 (0.7)9.3 (3.2)<0.001
 Male/female19/1712/2419/1715/210.55
 Age, year60.5 (8.9)60.5 (9.3)56.4 (10.0)54.3 (11.8)0.003
 FH*, yes/no21/1519/1718/1817/180.45
 G*, mg/day166.9 (45.0)182.2 (41.1)175.6 (46.1)173.7 (30.6)0.66
 M*, mg/day1648.6 (628.9)1779.2 (601.7)1784.7 (611.8)1577.1 (583.8)0.65
 BMI*, kg/m224.8 (2.9)24.8 (2.8)26.6 (5.3)28.5 (4.5)<0.001
 WC*, cm83.6 (7.6)83.4 (7.8)87.3 (9.1)93.0 (10.4)<0.001
 HC*, cm93.8 (5.9)93.9 (6.9)96.2 (8.6)99.8 (8.7)0.002
 SBP*, mmHg131.9 (16.0)135.9 (18.8)136.3 (15.6)139.3 (13.0)0.07
 DBP*, mmHg77.4 (7.8)79.5 (10.9)80.8 (9.6)80.5 (9.7)0.002
MSC, yes %
 LWC42.944.450.085.7<0.001
 HTN14.330.633.345.70.006
 HTG25.736.144.462.90.001
 LHDL51.475.058.365.70.484
Fasting serum factors
 Glucose, mg/dL169.3 (57.2)184.5 (48.6)198.2 (47.5)223.6 (63.0)<0.001
 HbA1c, %8.7 (1.5)8.7 (1.6)9.4 (1.8)9.8 (1.3)0.001
 Insulin, IU/mL4.6 (2.5)7.4 (1.9)10.8 (4.0)17.5 (5.9)<0.001
 Adiponectin, μg/mL19.1 (7.7)18.0 (7.0)15.3 (7.7)15.0 (6.2)0.006
Fasting lipoprotein
 Triglyceride, mg/dL130.9 (85.3)155.7 (95.3)189.3 (223.8)270.4 (404.6)0.01
 Cholesterol, mg/dL172.8 (33.9)174.9 (40.1)171.8 (30.3)194.9 (48.4)0.03
 HDL, mg/dL43.7 (8.9)45.2 (9.8)41.9 (8.3)42.8 (9.6)0.40
 LDL, mg/dL111.8 (30.8)108.4 (33.2)106.8 (30.9)121.8 (36.6)0.25

HOMA IR: HOMA insulin resistance index; FH: family history of type 2 diabetes disease; G: gliclazide; M: metformin; BMI: body mass index; WC: waist circumference; HC: hip circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; LWC: large waist circumference; HTN: high blood pressure; HTG: high triglyceride; LHDL: low HDL-cholesterol; HDL: HDL-cholesterol; LDL: LDL-cholesterol.